The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA Peptide Reclassification 2026: What It Means for Providers The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law